Branding clinical trials helps you begin building equity in your clinical asset in its earliest phases of development. Find out how this benefits you, your patients and even investors.
Creating a brand name with links back to the science of the product holds a number of benefits and advantages across your brand.
Mergers, acquisitions, restructurings – don’t let your brand suffer during times of change at the corporate level.
When creating a pharma brand name, the thin line must be walked between creating a name that will have both a strong opportunity for regulatory approval and the recipe for market success.
Creating and growing any business is a process that can take large amounts of time and energy to achieve – that’s a given. It’s a question we hear all of the time – “why do I need to create a brand? Why branding?”
How to build a brand in a way that successfully communicates the previously unseen nature of innovation? The answer can be found in one word – differentiation.
How often have you scanned the store shelves looking for a product, and a particular one caught your eye, making you stop, do a double-take or spend a few additional seconds focusing on that one product before moving on? Well, those few seconds and that additional look were not a coincidence.
It has been said that you never get a second chance to make a first impression. For many new assets the clinical trial stage of development is that first impression, a chance to ensure that moving forward, their brand is set up for success.
How can your colors push your brand forward, and what do you need to keep in mind when making decisions about your color palette?
Do you choose a name that is “safe” and has a good chance at regulatory approval, or to take the more “risky” route, with a name that might have a more difficult time getting approved but stands out?
Just like you wouldn't build a house without a blueprint created, you shouldn't build a brand without a brand architecture strategy in place. Find out why this strategic brand element can drive all of your brand development decisions.
Biosimilars are one of the most exciting breakthroughs in the pharmaceutical space in years, providing an entirely new category of products to reach patients. But with this new innovation comes new branding challenges.
If AI is the wave of the future, we must keep in mind the shortcomings: right now smart computer systems only consider the tip of the iceberg when it comes to drug naming.
Naming an OTC drug product is the rare instance in pharma naming when pre- and post-launch planning are so closely intertwined, which can pose some challenges. But it can also some uniquely interesting opportunities. What do you need to keep in mind when working on this type of product?
We’ve compiled answers for the 11 most frequently asked questions surrounding pharmaceutical branding we receive today to help you with your next project.
Is there something “off” with your brand, and you can’t figure out what it is? Chances are, your brand is in need of a refresh.
Is it possible to convey both competence and warmth in a logo? Unity and inclusion? Strength and kindness? The answer to all of the above is yes and no. It’s certainly possible for a logo to convey any or all of those things – just not on its own.
In the summer of 2015, Health Canada released an updated guidance for their name submission process. Almost two years later, found an impact that goes beyond the Canadian pharmaceutical market.